Temporal association of vitreous hemorrhage and hypertension after COVID-19 mRNA vaccines

Toshihiko Matsuo; Hiroshi Noda

doi:10.1002/ccr3.6657

Temporal association of vitreous hemorrhage and hypertension after COVID-19 mRNA vaccines

Clin Case Rep. 2022 Nov 27;10(11):e6657. doi: 10.1002/ccr3.6657. eCollection 2022 Nov.

Authors

Toshihiko Matsuo^{1

2}, Hiroshi Noda^{2

3}

Affiliations

¹ Graduate School of Interdisciplinary Science and Engineering in Health Systems Okayama University Okayama City Japan.
² Department of Ophthalmology Okayama University Hospital Okayama City Japan.
³ Department of Ophthalmology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama University Okayama City Japan.

Abstract

Vitreous hemorrhage as common eye presentation and hypertension as common systemic presentation are difficult to designate whether they are coincidental or causal in terms of adverse events of COVID-19 vaccinations. Temporal association of hypertension and vitreous hemorrhage was noted in a patient repeatedly after the second and third COVID-19 vaccinations.

Keywords: COVID‐19 mRNA vaccine; hypertension; retinal hemorrhage; retinal tear; vitreous hemorrhage.

Publication types

Case Reports